Back to search
Verruca (Warts)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Verruca (Warts) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Verruca (Warts) trials you may qualify forBackground: * Idiopathic CD4+ lymphocytopenia (ICL) is a condition in which there is a decreased level of CD4+ lymphocytes (a type of white blood cell), which…
Background: * WHIMS (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome) is caused by various genetic changes that increase the activity of t…
People who participated in either the COVE-2 or COVE-3 study for common warts, may be eligible to enroll into this Long Term Follow Up (LTFU) study COVE-4. The…
1. Background of the Problem Viral warts result from infection of the skin or mucous membranes by human papillomavirus (HPV). Some patients develop refractory c…
This is a comparative study between two treatment options for skin viral infection.
Warts are common, benign skin lesions caused by the human papillomavirus (HPV). Treatment is challenging, particularly in the pediatric population, where standa…
this study aims to compare the efficacy and safety of platelet rich fibrin injection versus intralesional vitamin D injection in the treatmentof common warts. P…
Patients between 4-21 years of age with at least one wart or molluscum lesion are eligible to participate in this study. The duration of the study is a minimum…
Traditionally, healers are willing to look after, two out of three French citizens have already appealed to them at least once during their lives. Many healers…